Sign In
Buy TMCI
$3.69
+0.290 (+8.53%)
At Close: Jun 04, 2026
Treace Medical Concepts (TMCI) Moves 8.2% Higher: Will This Strength Last?
11:48am, Monday, 20'th Jun 2022 Zacks Investment Research
Treace Medical Concepts (TMCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further pric
Treace Medical Concepts (TMCI) Moves 8.2% Higher: Will This Strength Last?
09:20am, Monday, 20'th Jun 2022
Treace Medical Concepts (TMCI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further pric
Benzinga's Top Ratings Upgrades, Downgrades For May 12, 2022
02:04pm, Thursday, 12'th May 2022 Benzinga
Upgrades
For Warner Bros.Discovery Inc (NASDAQ:WBD), Cowen & Co. upgraded the previous rating of Market Perform to Outperform. The current stock performance of Warner Bros.Discovery shows a 52-week-h
Treace Medical Concepts, Inc. (TMCI) CEO John Treace on Q1 2022 Results - Earnings Call Transcript
03:04am, Sunday, 08'th May 2022
Treace Medical Concepts, Inc. (NASDAQ:TMCI ) Q1 2022 Earnings Conference Call May 5, 2022 4:30 PM ET Company Participants Vivian Cervantes - Investor Relations John Treace - Chief Executive Officer Ma
Treace Medical Concepts, Inc. (TMCI) Q1 2022 Earnings Call Transcript
01:01pm, Friday, 06'th May 2022 The Motley Fool
TMCI earnings call for the period ending March 31, 2022.
Treace Medical Concepts (TMCI) Reports Q1 Loss, Tops Revenue Estimates
10:25pm, Thursday, 05'th May 2022 Zacks Investment Research
Treace Medical Concepts (TMCI) delivered earnings and revenue surprises of 20% and 10.95%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Treace Medical Concepts Reports First Quarter 2022 Financial Results
08:05pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in th
Treace Announces Peer-Reviewed Publication of ALIGN3D™ Multicenter Prospective Clinical Data
12:15pm, Thursday, 05'th May 2022 GlobeNewswire Inc.
PONTE VEDRA, Fla., May 05, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of
Treace Secures Up to $150 Million in Debt Financing
12:00pm, Monday, 02'nd May 2022 GlobeNewswire Inc.
PONTE VEDRA, Fla., May 02, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in the
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
08:15pm, Thursday, 14'th Apr 2022 GlobeNewswire Inc.
PONTE VEDRA, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a paradigm shift in the surgical treatment o
Treace to Report First Quarter 2022 Financial Results on May 5, 2022
04:15pm, Thursday, 14'th Apr 2022
PONTE VEDRA, Fla., April 14, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace”) (NasdaqGS: TMCI), a medical technology company driving a paradigm shift in the surgical treatment of
Treace Files Patent Infringement Suit To Protect Lapiplasty® Bunion Technology
08:15pm, Monday, 28'th Mar 2022 GlobeNewswire Inc.
PONTE VEDRA, Fla., March 28, 2022 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (Nasdaq: TMCI), a medical technology company driving a fundamental shift in th
Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript
05:00am, Friday, 04'th Mar 2022 The Motley Fool
TMCI earnings call for the period ending December 31, 2021.
Treace Medical Concepts, Inc. (TMCI) Q4 2021 Earnings Call Transcript
05:00am, Friday, 04'th Mar 2022 The Motley Fool
TMCI earnings call for the period ending December 31, 2021.
